MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
Patients across the Middle East, Europe, and surrounding regions increasingly ask whether they can access MUSE stem cells without traveling across the globe. R3 Stem Cell, led by Founder and CEO Dr. David Greene, now offers approved MUSE stem cell therapy at two premier international
When joint pain, back pain, or a sports injury stops you from doing what you love, the usual advice can feel limited: rest, medication, therapy, or surgery. That is why a growing number of people ask their doctors about stem cell therapy, a form of
If you suffer from chronic knee pain, you have likely tried physical therapy, cortisone shots, and hyaluronic acid lubricants. When those stop working, many patients feel backed into a corner, assuming a total knee replacement is their only remaining option. But does stem cell
The average stem cell therapy cost ranges between $3,500 for a single joint injection and over $15,000 for advanced systemic protocols, with nearly all of it paid completely out-of-pocket. Because commercial insurers and Medicare do not cover non-FDA-approved regenerative interventions, private clinics operate on a
Receiving a diagnosis of Premature Ovarian Failure (POF)—medically referred to as Primary Ovarian Insufficiency (POI)—is one of the most heartbreaking moments a woman in her reproductive years can face. Defined by the loss of normal ovarian function before age 40, POF abruptly cuts short dreams
By Dr. David Greene, MD, PhD, MBA, Founder and CEO of R3 Stem Cell If you’re considering regenerative treatment with R3 Stem Cell, you may have seen news about a warning letter the U.S. Food and Drug Administration (FDA) sent us in August 2026. Some
A tweaked hamstring in the middle of a season. A sore elbow that never quite settles down. An ankle that rolled one too many times. Soft tissue injuries are part of life for anyone who trains hard, and they have a way of dragging on
For decades, standard orthopedic medicine taught that once articular cartilage wears away, it cannot return. Because articular cartilage is avascular, lacking blood vessels to deliver oxygen, nutrients, and immune cells, the traditional progression for joint decay has been predictable: mask pain with steroid shots, inject
If you are researching stem cell therapy for your child with autism, you have probably seen two very different messages. Clinics say the treatment is safe, carefully screened, and gentle. Doctors and regulators say it is unproven and may be dangerous. Both can sound convincing,
If you or someone you love has multiple sclerosis, you’ve probably asked this question and found conflicting answers. Some websites promise reversal. Others say nothing works. The honest answer is in between, and it matters most for anyone researching stem cell therapy for multiple sclerosis.
